Skip to main content
Belgium

Belgium

Alexion Mission

At Alexion, our mission is to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, as well as supportive technologies and healthcare services.

For over three decades, patients and their caregivers have been at the centre of everything we do. Everyday, we are inspired to think differently and follow the science in order to create better outcomes for them and their families. Our mission is driven by understanding who they are as unique individuals, not just their disease


Alexion in Belgium

Alexion has been operating in Belgium since 2007 and works to provide optimal care for patients affected by a rare disease.

Rare Diseases Supported in Belgium

In Belgium, we work across various rare diseases and devastating conditions, including:

Paroxysmal Nocturnal Haemoglobinuria (PNH)

A rare, chronic, progressive and potentially life-threatening blood disorder. It is characterised by red blood cell destruction within blood vessels (also known as intravascular haemolysis) and white blood cell and platelet activation, which can result in thrombosis (blood clots).

Atypical Haemolytic Uraemic Syndrome (aHUS)

A rare disease that can cause progressive injury to vital organs, primarily the kidneys, via damage to the walls of blood vessels and blood clots.

Generalised Myasthenia Gravis (gMG)

A rare, autoimmune neuromuscular disease characterised by loss of muscle function and severe muscle weakness.

Neuromyelitis Optica Spectrum Disorder (NMOSD)

A rare autoimmune disease of the central nervous system, characterised by unpredictable relapses which can result in cumulative disability.

Medicines

Our medicines available in Belgium:

Soliris

Ultomiris

Clinical Trials

Clinical Trials

Alexion is committed to serving people affected by rare diseases through the discovery, development and access of life-changing medicines. Our goal is to bring safe and effective medicines to as many patients as possible by conducting rigorous clinical trials and obtaining marketing approval by regulatory authorities around the world. Our work is marked by a commitment to the highest standards of preclinical and clinical research, and an acute sense of urgency. As such, we prioritize access to our investigational medicines through participation in a clinical trial.

Contact us
Careers

Career Opportunities

At Alexion, we foster an environment that attracts and retains the best talent. We provide the tools to enable each individual to perform at their personal best so that we maximize our collective impact.

Explore Careers

Contact Information

Product Quality Complaint or an Adverse Event

Please report a Product Quality Complaint or an Adverse Event using the CHAMPion form. You can also submit a medical information inquiry using this form.

Medical Information

Please contact medinfo@alexion.com

Orders

Please contact CustomeroperationsBenelux@alexion.com

Pharmacovigilance

Please contact patientsafety.belgium@astrazeneca.com

Quality

Please contact Quality.Belux@alexion.com

Belgium Office

Alexion Pharma Belgium

Rue des Deux Églises 29-33
Tweekerkenstraat 29-33
1000 Brussels
Belgium

+32 (0)800 20 031

Veeva ID: BE/NP/0013

Date of Preparation: March 2025

Leaving Our Site

You are now going to another site.